Plasma NT pro-BNP, hs-CRP and big-ET levels at admission as prognostic markers of survival in hospitalized patients with dilated cardiomyopathy: a single-center cohort study


Circulating N-terminal pro-B-type natriuretic peptide (NT pro-BNP), high- sensitivity C-reactive protein (hs-CRP) and big endothelin (big-ET) have been shown to be increased in heart failure and to contribute to both hemodynamic deterioration and cardiovascular remodeling. Here, we examined the prognostic value of the three neurohormones at admission in a population of hospitalized patients with dilated cardiomyopathy (DCM).Methods and results: This cohort study was undertaken in 622 hospitalized patients with DCM in Fuwai Hospital from January 2005 to September 2011 (female 26.5%, 51.4 +/- 14.6 years old).

Standard demographics, echocardiography and routine blood samples were obtained shortly after admission. NT pro-BNP, hs-CRP and big-ET were measured, and their concentrations in relation to all-cause mortality were assessed through a mean follow-up of 2.6 +/- 1.6 years.

Kaplan-Meier curves showed that the all-cause mortality rates were higher in patients with NT pro-BNP 2247 pmol/L compared to patients with NT pro-BNP 3.90 mg/L compared to patients with hs-CRP 0.95 pmol/L compared to patients with big-ET

Conclusions:
In a large population of patients with DCM, the circulating concentrations of NT pro-BNP and hs-CRP, but not big-ET, were independent markers of all-cause mortality.

Author: Xiaoping LiChengzhi ChenFeng GanYang WangLigang DingWei Hua
Credits/Source: BMC Cardiovascular Disorders 2014, 14:67

Published on: 2014-05-11

Tweet

News Provider: 7thSpace Interactive

Social Bookmarking
RETWEET This! | Digg this! | Post to del.icio.us | Post to Furl | Add to Netscape | Add to Yahoo! | Rojo

There are no comments available. Be the first to write a comment.